Pal SK, Figlin RA, Yu H. Deciphering the anticancer mechanisms of sunitinib. Cancer Biol Ther 2010 Oct 24;10(7). [Epub ahead of print] (PMID: 20716960)

Pal SK, Reckamp K, Yu H, Figlin RA. Akt inhibitors in clinical development for the treatment of cancer. Expert Opin Investig Drugs 2010 Sep 16. [Epub ahead of print] (PMID: 20846000)

Agrawal K, Onami S, Mortimer JE, Pal SK: Cognitive changes associated with endocrine therapy for breast cancer. Maturitas 2010 Aug 3. [Epub ahead of print] (PMID: 20688441)

Pal SK, Hurria A: The impact of age, gender and co-morbidity on cancer therapy and disease progression. J Clin Oncol 2010 Jul 19. [Epub ahead of print] (PMID: 20644100)

Pal SK, Figlin RA, Reckamp K: Targeted therapies for non-small cell lung cancer: an evolving landscape. Mol Cancer Ther 2010 Jun 22. [Epub ahead of print] (PMID: 20571071)

Pal SK, Figlin RA. Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors. Clin Med Insights Oncol 2010 Jun 9;4:43-53. (PMID: 20711245)

Pal SK, Lau SK, Kruper L, et al: Papillary carcinoma of the breast: an overview. Breast Cancer Res Treat 2010 Jun 4. [Epub ahead of print] (PMID: 20524058)

Lee H, Pal SK, Reckamp K, Figlin RA, Yu H. STAT3: A Target to Enhance Antitumor Immune Response. Curr Top Microbiol Immunol. 2010 Jun 2. [Epub ahead of print] (PMID: 20517723)

Mortimer JE, Pal SK. Safety considerations for use of bone-targeted agents in patients with cancer. Semin Oncol 2010 Jun;37 Suppl 1:S66-72. (PMID: 20682374)

Naeim A, Wong FL, Pal SK, Hurria A: Oncologists’ recommendations for adjuvant therapy in hormone-receptor positive breast cancer patients of varying age and health status. Clin Breast Cancer 2010; 10(2):136-43. (PMID: 20353934)

Onami S, Ozaki M, Mortimer J, Pal SK: Male breast cancer: An update in diagnosis, treatment and molecular profiling. Maturitas 2010; 65(4):308-14. (PMID: 20138719)

Pal SK, Childs B, Pegram M: Emergence of nonanthracycline regimens in the adjuvant treatment of breast cancer. Breast Cancer Res Treat 2010; 119(1):25-32. (PMID: 19795206)

Pal SK, Figlin RA: Pazopanib: carving a niche in a crowded therapeutic landscape. Nat Rev Clin Oncol 2010; 7(7):362-3. (PMID: 20592710)

Pal SK, Figlin RA: Renal cell carcinoma in 2010: Many options with little comparative data. Clin Adv Hematol Oncol 2010; 8(3):191-200. (PMID: 20400934)

Pal SK, Katheria V, Hurria A: Evaluating the older patient with cancer: Understanding frailty and the geriatric assessment. CA Cancer J Clin 2010; 60(2):120-32. (PMID: 20173172)

Hurria A, Wong FL, Pal SK, et al: Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER2-positive breast cancer: A survey of oncologists. The Oncologist 2009; 14(9):883-90. (PMID: 19726455)

Pal SK, Gupta R, Dosik G, Figlin R: Concomitant renal cell carcinoma and chronic myelogenous leukemia: Utilization of a targeted approach. Current Oncol 2009; 16(2):44-7. (PMID: 19370179)

Pal SK, Mortimer J: Adjuvant chemotherapy for older adults with breast cancer: making the standard a standard. Women’s Health 2009; 5(5):481-4. (PMID: 19702447)

Pal SK, Mortimer J: Triple-negative breast cancer: Novel therapies and new directions. Maturitas 2009; 63(4):269-74. (PMID: 19632796)

Pal SK, Mortimer J: Adjuvant systemic therapy for older adults with early-stage breast cancer. Women’s Health 2009; 5(3):251-62 (PMID: 19392611)

Pal SK, Twardowski P, Josephson DY: Beyond castration and chemotherapy: novel approaches to targeting androgen-driven pathways. Maturitas 2009; 64(2):61-6. (PMID: 19733987)

Pal SK, Reckamp KL, Figlin RA: The role of targeting mammalian target of rapamycin in lung cancer. Clin Lung Cancer 2008; 9(6):340-5. (PMID: 19073516)

Pal SK, Blazer K, Weitzel J, Somlo G: An association between invasive breast cancer and familial idiopathic hyperparathyroidism: A case series and review of the literature. Breast Cancer Res Treat 2008; 114(1):1-5. (PMID: 18500673)

Pal SK, Pegram M: HER2 targeted therapy in breast cancer … beyond Herceptin. Rev Clin Endo Metab Disorders 2007; 8(3):269-77. (PMID: 17899385)

Pal SK, Figlin RA: Mixed epithelial stromal tumor (MEST) of the kidney: a case report and review of the literature. Kidney Cancer J 2007; 5(2):85-86.

Pal SK, Hurria A: Breast cancer in the older patient. Oncological Disease 2007; 1(1):32-34.

Pal SK, Pegram M: Targeting HER2 epitopes. Semin Oncol 2006; 33(4):386-391. (PMID: 16890794)

Pal SK, Pegram M: Epidermal growth factor receptor and signal transduction: potential targets for anti-cancer therapy. Anticancer Drugs 2005; 16(5):483-94. (PMID: 15846113)

Schiller GJ, Said J, Pal SK: Hairy cell leukemia and sarcoidosis: a case report and review of the literature. Leukemia 2003; 17(10):2057-9. (PMID: 14513061)